♟️ Tuesday 7 April 2026 Tue, 7 Apr 2026

Loyal Metals Ltd (ASX:LLM) has reported assay results from drillhole 25HRDD003 at its Highway Reward Copper-Gold Project in Queensland, confirming a large, continuous VHMS Copper-Gold-Silver system. The 179m intersection at 1.47% copper equivalent supports a bulk-style mining opportunity distinct from historical narrow-lens models.

National Storage REIT (ASX:NSR) has confirmed satisfaction of key foreign investment conditions for its proposed acquisition by a Brookfield-GIC consortium, with securityholder meetings scheduled for mid-April.

Elanor Investors Group has completed documentation for a $125 million balance sheet recapitalisation with Rockworth Capital Partners, preparing to release HY26 financial results and advance leadership renewal and rebranding initiatives.

Recharge Metals Limited has completed the acquisition of the Sunset Well Gold Project in Western Australia's Leonora district, securing a near-surface inferred gold resource of 94,500 ounces. The company raised approximately A$5.97 million through a placement and rights issue, bolstering its funding and leadership team to advance exploration activities.

St George Mining Limited (ASX: SGQ) has announced exceptional diamond drilling results from its Araxá Rare Earths and Niobium Project in Brazil, including the thickest intercept to date of 178.7m at 4.34% TREO and 0.75% Nb2O5 from surface. These results reinforce Araxá's status as a world-class undeveloped resource with potential for dual revenue streams from rare earths and niobium.

Latitude 66 Limited has lodged Exploration Permit applications for its KSB Project in northern Finland following a recent amendment to the Finnish Mining Act. The permits, expected in Q2 2026, will secure tenure for the project and enable further development and exploration activities.

Cue Energy Resources Limited’s Independent Board Committee has unanimously advised shareholders to reject Horizon Oil Limited’s off-market takeover offer, citing undervaluation and significant risks. Shareholders are urged to take no action in response to the offer.

Patagonia Lithium Ltd (ASX:PL3) has announced positive exploration results from Well JAM 25-05 at its Formentera Lithium Project in Argentina, with core analysis revealing porosity values above regional averages and lithium assays ranging from 156ppm to 219ppm. These findings may support an expansion of the company’s Mineral Resource Estimate (MRE).

Bank of Queensland (ASX: BOQ) has announced a strategic capital partnership with Challenger Limited (ASX: CGF), involving a $3.7 billion whole-of-loan sale and a forward flow arrangement for equipment finance assets. The deal aims to optimise BOQ’s funding base, support SME equipment finance growth, and enable capital returns to shareholders.

OD6 Metals has reported exceptional assay results from the Mammoth prospect within its Quinn Fluorspar Project in Nevada, confirming high-grade fluorspar mineralisation up to 53.2% CaF2 and indicating potential for a broader mineralised system.

ImpediMed Limited has appointed Erik Anderson as its new CEO and Managing Director, effective 7 April 2026, aiming to boost commercial execution and revenue growth in the US market. Dr Parmjot Bains will remain as an advisor until 30 June 2026 to ensure a smooth leadership transition.

Fortuna Metals Limited (ASX:FUN) has announced a conceptual exploration target of 180 to 240 million tonnes at 0.86 to 1.0% rutile grade for its Mkanda project in Malawi, with major drilling programs planned in 2026 to advance resource definition.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

Rox Resources Limited has executed a A$350 million syndicated debt facility agreement with major banks to fund the development of its Youanmi Gold Project, targeting first gold production by mid-2027.

Nexsen Limited (ASX:NXN) has completed its Stage 1 ISO 13485 audit, confirming its Quality Management System (QMS) supports clinical validation and regulatory submissions for its diagnostic products, including StrepSure®. The company is progressing toward full certification and alignment with MDSAP requirements to facilitate global market access.